Stock Analysis

Sunac China Holdings Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags

SEHK:1918
Source: Shutterstock

Sunac China Holdings (HKG:1918) Full Year 2023 Results

Key Financial Results

  • Revenue: CN¥154.2b (up 59% from FY 2022).
  • Net loss: CN¥7.97b (loss narrowed by 71% from FY 2022).
  • CN¥1.43 loss per share (improved from CN¥5.16 loss in FY 2022).
earnings-and-revenue-growth
SEHK:1918 Earnings and Revenue Growth April 29th 2024

All figures shown in the chart above are for the trailing 12 month (TTM) period

Sunac China Holdings Revenues Beat Expectations, EPS Falls Short

Revenue exceeded analyst estimates by 62%. Earnings per share (EPS) missed analyst estimates by 114%.

Looking ahead, revenue is expected to decline by 19% p.a. on average during the next 3 years, while revenues in the Real Estate industry in Hong Kong are expected to grow by 5.2%.

Performance of the Hong Kong Real Estate industry.

The company's shares are up 51% from a week ago.

Risk Analysis

Be aware that Sunac China Holdings is showing 3 warning signs in our investment analysis and 2 of those are concerning...

Valuation is complex, but we're helping make it simple.

Find out whether Sunac China Holdings is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.

View the Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.